Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
Open accessThe DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.
Abstract
Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to their capacity for local engrafting and differentiating into multiple tissue types. However, recent studies have revealed that implanted cells do not survive for long, and that the benefits of MSC therapy could be due to the vast array of bioactive factors they produce, which play an important role in the regulation of key biologic processes. Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product. Nevertheless, regulatory requirements for manufacturing and quality control will be necessary to establish the safety and efficacy profile of these products. Among MSCs, human uterine cervical stem cells (hUCESCs) may be a good candidate for obtaining secretome-derived products. hUCESCs are obtained by Pap cervical smear, which is a less invasive and painful method than those used for obtaining other MSCs (for example, from bone marrow or adipose tissue). Moreover, due to easy isolation and a high proliferative rate, it is possible to obtain large amounts of hUCESCs or secretome-derived products for research and clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 1×
“The Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy established in 2006 the minimal identifying characteristics for human MSCs [29]: (a) plastic-adherent cells when maintained in standard culture conditions; (b) expression of CD105, CD73 and CD90, and lack expression of CD4…”
BackgroundValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo
Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., & Shi, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240309797 · Cited by 4,570 · cited 1×
“They have also been isolated from other adult tissues such as adipose tissue [10], skin [11], lung [12], synovial membrane [13], dental pulp [14], nasal olfactory mucosa [15], breast milk [16], scalp tissue [17], muscle [18], periosteum [19], corneal limbus [20], peripheral blood [21], endometrial and menstrual blood…”
BackgroundA perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991 · cited 1×
“All of these MCSs can be isolated and expanded from stroma of many tissues, the bone marrow and subcutaneous fat being the preferred sources [28].”
BackgroundDi Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226 · cited 1×
“found that MSCs inhibit proliferation of CD4+ and CD8+ T cells [78].”
BackgroundMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734 · cited 1×
“The most promising potential applications involve the treatment of graft versus host disease [74,75], as well as of autoimmune and inflammatory diseases, such as insulin systemic lupus erythematosus (SLE), diabetes mellitus type I, (SLE), multiple sclerosis or Crohn’s”
BackgroundFriedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“[9], who described a fibroblast-like population able to secrete growth factors and cytokines relevant for hematopoiesis and others processes.”
BackgroundNémeth, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302 · cited 1×
“This is relevant because CAFs, a prevailing component of tumor stroma, contribute to tumor growth, invasion and dissemination [145,146].”
Background
Research works printed but not linked: 1
- 95. Litwack G. Human Biochemistry and Disease. Academic Press; Cambridge, MA, USA: 2008.
Cited by
Items 201–300 of 1,000
Serhal, R., Saliba, N., Hilal, G., Moussa, M., Hassan, G. S., Atat, O. E., & Alaaeddine, N. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i5.567 · Cited by 54
Stojanović, S., & Najman, S. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071671 · Cited by 50
Extracellular vesicles miRNA-21: a potential therapeutic tool in premature ovarian dysfunction
Thabet, E. H., Yusuf, A., Abdelmonsif, D. A., Nabil, I., Mourad, G. M., & Mehanna, R. A. (2020) · Molecular Human Reproduction · doi:10.1093/molehr/gaaa068 · Cited by 53
Sun, X., Mao, Y., Liu, B., Gu, K., Liu, H., Du, W., Li, R., & Zhang, J. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13020180 · Cited by 51
“It was reported that mesenchymal-stem-cell (MSC)-derived exosomes function in tissue regeneration [24].”
BackgroundMesenchymal Stem Cell Derived Exosomes Therapy in Diabetic Wound Repair
Jing, S., Li, K., & Xu, H. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s411562 · Cited by 52
“6 Due to the heterogeneity of MSCs derived from different tissues, the contents of exosomes may differ from each other, so as do the roles in diabetic wound healing.”
Mandal, S., Arfuso, F., Sethi, G., Dharmarajan, A., & Warrier, S. R. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.02.001 · Cited by 51
Mesenchymal Stem Cells Modulate the Immune System in Developing Therapeutic Interventions
Rawat, S. J., Gupta, S., & Mohanty, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80772 · Cited by 55
“[85] identified exosomes as the cardioprotective components in MSC paracrine secretion [84].”
BackgroundMattei, A., Bertrand, B., Jouve, É., Blaise, T., Philandrianos, C., Grimaud, F., Giraudo, L., Aboudou, H., Dumoulin, C., Arnaud, L., et al. (2020) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2019.4328 · Cited by 51
Lv, X., Guan, C.-Y., Li, Y., Su, X., Zhang, L., Wang, X., Xia, H., & Ma, X. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00871-4 · Cited by 52
Navarro, L., Chen, X., Viviescas, L. T. G., Ardila-Roa, A. K., Luna-González, M., Sossa, C., & Arango-Rodríguez, M. L. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03043-3 · Cited by 55
Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia
Shirbaghaee, Z., Hassani, M., Keshel, S. H., & Soleimani, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03148-9 · Cited by 53
“More research is needed to investigate this, and if prosperous, these findings could reveal a new occasion for the cell-free treatment [146].”
BackgroundMukherjee, S., Yadav, G., & Kumar, R. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i6.521 · Cited by 54
Polymeric Hydrogels as Mesenchymal Stem Cell Secretome Delivery System in Biomedical Applications
Arifka, M., Wilar, G., Elamin, K. M., & Wathoni, N. (2022) · Polymers · doi:10.3390/polym14061218 · Cited by 53
“The MSC-derived secretome contains a wide variety of pro-regenerative factors (a mixture of secreted factors, including soluble proteins, free nucleic acids, lipids, and extracellular vesicles), MSCs as a new type of regenerative medicine through non-invasive therapeutic cellular approaches so that it can overcome the…”
BackgroundYamaguchi, N., Horio, E., Sonoda, J., Yamagishi, M., Miyakawa, S., Murakami, F., Hasegawa, H., Katahira, Y., Mizoguchi, I., Fujii, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413562 · Cited by 54
Taheri, B., Soleimani, M., Fekri Aval, S., Esmaeili, E., Bazi, Z., & Zarghami, N. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27775 · Cited by 46
Yuan, Q., Zhang, Y., & Chen, Q. (2019) · The Anatomical Record · doi:10.1002/ar.24186 · Cited by 52
“Most of the initial efforts were made to find bioactive therapeutic factors secreted by the MSC including cytokines, chemokines, and growth factors (Vizoso et al., 2017).”
Carluccio, M., Ziberi, S., Zuccarini, M., Giuliani, P., Caciagli, F., Iorio, P. D., & Ciccarelli, R. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09703-4 · Cited by 57
“The secretome of individual cells and tissues is specific and changes in response to fluctuations in physiological states or pathological conditions [250].”
BackgroundAraldi, R. P., D’Amelio, F., Vigerelli, H., de Melo, T. C., & Kerkis, I. (2020) · Cells · doi:10.3390/cells9122663 · Cited by 48
Cui, L., Luo, W. P., Jiang, W., Li, H., Xu, J., Liu, X., Wang, B., Wang, J., & Chen, G. (2022) · Regenerative Therapy · doi:10.1016/j.reth.2022.07.005 · Cited by 50
“Compared with MSCs, exosomes have the characteristics of good biocompatibility, long in vivo half-life, and easy extraction and storage, so they have gradually become a research hotspot [16,17].”
BackgroundChen, L., Zhu, S., Guo, S., & Tian, W. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03242-6 · Cited by 54
Ryu, Y., Hwang, J. S., Noh, K. B., Park, S. H., Seo, J. H., & Shin, Y. J. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.13.29 · Cited by 50
“39 In this study, we investigated the effects and mechanisms of action of ASC-derived exosomes on promoting the wound healing and migration of CECs.”
BackgroundHenstock, J. R., Rotherham, M., & Haj, A. J. E. (2018) · Journal of Tissue Engineering · doi:10.1177/2041731418808695 · Cited by 47
Wragg, N. M., Burke, L., & Wilson, S. L. (2019) · Renal Replacement Therapy · doi:10.1186/s41100-019-0218-7 · Cited by 49
Rhatomy, S., Prasetyo, T. E., Setyawan, R., Soekarno, N. R., Romaniyanto, F., Sedjati, A. P., Sumarwoto, T., Utomo, D. N., Suroto, H., Mahyudin, F., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0388 · Cited by 53
“It may be also modified for desired effects and can reduce cost and time for production and maintenance of cell-based therapy.(5) Previous in vitro studies of stem cells CM or secretome usage showed promising outcomes.”
BackgroundInfluentialThe progress in corneal translational medicine
Hancox, Z., Keshel, S. H., Yousaf, S., Saeinasab, M., Shahbazi, M.-A., & Sefat, F. (2020) · Biomaterials Science · doi:10.1039/d0bm01209b · Cited by 51
Lee, C., Kim, M., Han, J., Yoon, M., & Jung, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9111598 · Cited by 43
Rumman, M., Majumder, A., Harkness, L., Venugopal, B., Vinay, M. B., Pillai, M. S., Kassem, M. S., & Dhawan, J. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.05.010 · Cited by 49
Regenerative Potential of Mesenchymal Stem Cells’ (MSCs) Secretome for Liver Fibrosis Therapies
Ignat, S.-R., Gharbia, S., Hermenean, A. O., Dinescu, S., & Costache, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413292 · Cited by 52
“Moreover, the content of MSC-sourced secretome could be modified for specific desired therapeutic effects [27].”
BackgroundInfluentialFat Graft Retention: Adipose Tissue, Adipose-Derived Stem Cells, and Aging
Trotzier, C., Sequeira, I., Auxenfans, C., & Mojallal, A. A. (2022) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000009918 · Cited by 54
Usategui‐Martín, R., Puertas‐Neyra, K., García-Gutiérrez, M.-T., Fuentes, M., Jimeno, J. C. P., & Fernandez‐Bueno, I. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.003 · Cited by 52
“Besides, handling and storage of compositions based in the MSC secretome present important advantages over living cells in clinical practice.(39)”
Chugh, R. M., Park, H.-S., Esfandyari, S., Elsharoud, A., Ulin, M., & Al-Hendy, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179184 · Cited by 51
“liver injury or fibrosis [17], myocardial infarction, spinal cord injury, and wound healing [18].”
BackgroundMesenchymal Stem Cell-Derived Apoptotic Bodies: Biological Functions and Therapeutic Potential
Tang, H., Luo, H., Zhang, Z., & Yang, D. (2022) · Cells · doi:10.3390/cells11233879 · Cited by 47
“Responding to stimulation factors, MSCs secrete growth factors, chemokines, cytokines, and other active factors to exert their pleiotropic actions [15], such as alleviating inflammation [16], regulating immune response [17], and promoting tissue repair [18].”
BackgroundAdamo, G., Santonicola, P., Picciotto, S., Gargano, P., Nicosia, A., Longo, V., Aloi, N., Romancino, D. P., Paterna, A., Rao, E., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06612-9 · Cited by 44
Immune Response Activation and Immunomodulation
Tyagi, R. K., & Bisen, P. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73708 · Cited by 47
BDNF‐overexpressing human mesenchymal stem cells mediate increased neuronal protection in vitro
Scheper, V., Schwieger, J., Hamm, A., Lenarz, T., & Hoffmann, A. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24488 · Cited by 49
Caseiro, A. R., Pedrosa, S. S., Ivanova, G. I., Branquinho, M., ALMEIDA, A. A., Faria, F., Amorim, I., Pereira, T., & Maurício, A. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221378 · Cited by 54
Translational Animal Models Provide Insight Into Mesenchymal Stromal Cell (MSC) Secretome Therapy
Harman, R. M., Marx, C., & de Walle, G. R. V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.654885 · Cited by 50
“The pioneering studies of the effects of these secreted factors on specific target cells or in experimental rodent models have been extensively reviewed elsewhere (Vizoso et al., 2017; Abbasi-Malati et al., 2018; Eljarrah et al., 2019; Harrell et al., 2019).”
BackgroundFoodborne pathogens in the omics era
Vieira, K. C. D. O., da Silva, H. R. A., Rocha, I. P. M., Barboza, E., & Winkelströter, L. K. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1905603 · Cited by 47
“In addition, the secretomes also participate in the regulation of several physiological processes which include genetic material, hormones, soluble proteins, and lipids (Vizoso et al. 2017; Beer et al. 2017).”
BackgroundStem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?
Bonaventura, G., Munafò, A., Bellanca, C. M., Cognata, V. L., Iemmolo, R., Attaguile, G. A., Mauro, R. D., Benedetto, G. D., Cantarella, G., Barcellona, M. L., et al. (2021) · Cells · doi:10.3390/cells10081992 · Cited by 46
“This stem cell paracrine action is characterized by the release of a set of modulating molecules, including cytokines, chemokines, and growth/trophic factors, defined, as a whole, as secretome [48].”
BackgroundExosomes Derived From Mesenchymal Stem Cells: Novel Effects in the Treatment of Ischemic Stroke
Xiong, Y., Song, J., Huang, X., Pan, Z., Goldbrunner, R., Stavrinou, L. C., Lin, S., Hu, W., Zheng, F., & Stavrinou, P. C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.899887 · Cited by 49
Different pro-angiogenic potential of γ-irradiated PBMC-derived secretome and its subfractions
Wagner, T., Traxler, D., Simader, E., Beer, L., Narzt, M., Грубер, Ф., Madlener, S., Laggner, M., Erb, M., Vorstandlechner, V., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-36928-6 · Cited by 46
From synthetic biology to human therapy: engineered mammalian cells
Scheller, L., & Fussenegger, M. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.02.023 · Cited by 46
Mehrabadi, S., Motevaseli, E., Sadr, S. S., & Moradbeygi, K. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112362 · Cited by 45
Stem cell therapy: old challenges and new solutions
Balistreri, C. R., FALCO, E. D., Bordin, A., Maslova, O., Koliada, A. K., & Vaiserman, A. M. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05353-2 · Cited by 53
Taei, A. A., Dargahi, L., Nasoohi, S., Hassanzadeh, G., Kadivar, M., & Farahmandfar, M. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29981 · Cited by 43
Brave, H., & MacLoughlin, R. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176435 · Cited by 46
“Secretome is specific and can alter in response to changes in physiological and pathological states and conditions [41].”
BackgroundMethodInfluentialMenezes, K., da Rosa, B. G., Freitas, C., da Cruz, A. S., Santos, R. D. S., Nascimento, M. A., Lopes, D. V., Bonamino, M., Rossi, M. I. D., Borojević, R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76290-0 · Cited by 45
Marrazzo, P., Pizzuti, V., Zia, S., Sargenti, A., Gazzola, D., Roda, B., Bonsi, L., & Alviano, F. (2021) · Antibiotics · doi:10.3390/antibiotics10070750 · Cited by 43
Zeng, W., & Guo, L. (2021) · Annals of Dermatology · doi:10.5021/ad.2021.33.4.309 · Cited by 44
Vatsa, P., Negi, R., Ansari, U. A., Khanna, V., & Pant, A. B. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02603-7 · Cited by 45
“Although to achieve safe and efficient cell-based products, statutory requirements are needed for manufacturing and quality control [5].”
BackgroundAna, I. D., Barlian, A., Hidajah, A. C., Wijaya, C. H., Notobroto, H. B., & Wungu, T. D. K. (2021) · Future Science OA · doi:10.2144/fsoa-2021-0050 · Cited by 46
Salhab, O., Khayat, L., & Alaaeddine, N. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00863-6 · Cited by 47
“Because of this, they are widely used for hair regeneration due to stressful events [2, 11].”
BackgroundIşıldar, B., Özkan, S., Erçin, M., Gezginci-Oktayoğlu, S., Öncül, M., & Koyutürk, M. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00241-7 · Cited by 47
“It has been revealed that the secretome consists of cytokines such as IL-4; IL-6; IL-10; growth factors such as TGF-β1, HGF, and VEGF; and immunomodulatory molecules such as HLA-G, PGE2, and chemokines [10].”
BackgroundLi, Y., Chen, Y.-H., Liu, B., Nie, Q., Li, L., Duan, X., Wu, L., & Chen, G. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202453 · Cited by 46
Exosomes from mesenchymal stem cells: Potential applications in wound healing
Li, S., Li, Y., Zhu, K., He, W., Guo, X., Wang, T., Gong, S., & Zhu, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123066 · Cited by 47
Rahbarghazi, R., Keyhanmanesh, ., Aslani, M. R., Hassanpour, M., & Ahmadi, M. (2018) · Microvascular Research · doi:10.1016/j.mvr.2018.10.005 · Cited by 42
Mirabdollahi, M., Javanmard, S. H., & Sadeghi‐Aliabadi, H. (2019) · Cell and Tissue Banking · doi:10.1007/s10561-019-09781-8 · Cited by 46
Chudíčková, M., Vacková, I., Urdzíková, L. M., Jančová, P., Kekulová, K., Řehořová, M., Turnovcová, K., Jendelová, P., & Kubinová, Š. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184516 · Cited by 52
“Correspondingly, there are an increasing number of studies that demonstrate that the therapeutic effect of MCSs can be mediated by their secretome, which can be present in the medium where the stem cells were cultured [14,15].”
BackgroundMartin-Rufino, J. D., Espinosa‐Lara, N., Osugui, L., & Sanchez-Guijo, F. M. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00308 · Cited by 48
“However, paracrine signaling is currently regarded as the primarymode of action ofMSCs (Bi et al., 2007; Di Trapani et al., 2016; Vizoso et al., 2017; Ferreira et al., 2018).”
BackgroundMa, Y., Kakudo, N., Morimoto, N., Lai, F., Taketani, S., & Kusumoto, K. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1462-z · Cited by 52
“hASCs have been one of the most promising stem cells [2], the advantages of which are as follows: (1) hASCs can be ubiquitous and easily harvested in larger quantities without significant donor-site morbidity [3, 4]; (2) later senescence [5, 6], higher proliferation capacity [7], and more active in autocrine productio…”
BackgroundGauthaman, K., Alfakeeh, S. M., Bahmaid, A. O., Huwait, E. A., Gari, M. A., Abbas, M. M., Ahmed, F., Abu-Elmagd, M. M., & Pushparaj, P. N. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00646 · Cited by 43
Biomaterials reinforced MSCs transplantation for spinal cord injury repair
Ma, T., Wu, J., Mu, J., & Gao, J. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.03.003 · Cited by 53
Calcat-i-Cervera, S., Sanz‐Nogués, C., & O’Brien, T. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.728496 · Cited by 43
Mesenchymal stem cells for regenerative medicine in central nervous system
Li, M., Chen, H., & Zhu, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1068114 · Cited by 48
“Others demonstrated that pro-inflammatory stimuli and tri-dimensional growth stimulate trophic factors secretion of MSCs (Vizoso et al., 2017).”
BackgroundHached, F., Vinatier, C. S., Visage, C. L., Gondé, H., Guicheux, J., Grimandi, G., & Billon-Chabaud, A. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2018.05.002 · Cited by 44
Unveiling Mesenchymal Stromal Cells’ Organizing Function in Regeneration
Nimiritsky, P., Eremichev, R. Y., Alexandrushkina, N. A., Efimenko, A. Y., Va, T., & Макаревич, П. И. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040823 · Cited by 41
“Ubiquitous location in tissues and organs [40,41] Multipotency and high proliferative potential [42,43] Survival under stress conditions and inflammation [44,45] Immunomodulation and reduction of inflammation [29,46,47] Active pleiotropic secretome comprising of ECM components, growth factors, cytokines, and extracell…”
BackgroundMakino, E., Nakamura, N., Miyabe, M., Hiramatsu‐Ito, M., Kanada, S., Hata, M., Saiki, T., Sango, K., Kamiya, H., Nakamura, J., et al. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13045 · Cited by 42
Coelho, A. F., Alvites, R., Branquinho, M., Guerreiro, S. G., & Maurício, A. C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.602647 · Cited by 44
Wang, S., Dong, J., Li, L., Wu, R., Xu, L., Ren, Y., & Hu, X. (2021) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3268 · Cited by 43
Tang, J., Zhang, P., Liu, Y., Hou, D., Chen, Y., Cheng, L., Xue, Y., & Liu, J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122880 · Cited by 42
Chen, Y., Shen, J., Ke, K., & Gu, X. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04240-9 · Cited by 44
“Moreover, the secretome of stem cell administration may have several merits compare with stem cell transplantation directly from a clinical perspective in terms of manufacturing, storage, handling, and lack of immunosuppression-based adjuvant therapies [14].”
BackgroundFarfán, N., Carril, J., Redel, M., Zamorano, M., Araya, M., Monzón, E., Alvarado, R., Contreras, N., Tapia-Bustos, A., Quintanilla, M. E., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207800 · Cited by 45
“MSC-S can be evaluated for safety, dosage, and potency similarly to conventional pharmaceutical drugs, and is readily available since it can be lyophilized, favoring storage, and implying low factoring costs for large-scale production reutilizing the yielding cells [51].”
BackgroundGharbia, S., Ignat, S.-R., Dinescu, S., Baltă, C., Herman, H., Peteu, V. E., Gherghiceanu, M., Hermenean, A. O., & Costache, M. (2022) · Cells · doi:10.3390/cells11213338 · Cited by 43
“The many positive effects proven so far for MSCs’ secretome, such as immunomodulatory, anti-inflammatory activity, antiapoptotic activity, regulation of angiogenesis, and wound healing [23], recommend its use as possible treatment for liver fibrosis associated with DM.”
BackgroundKandeel, M. K., Morsy, M. A., Alkhodair, K. M., & Alhojaily, S. (2023) · Biomolecules · doi:10.3390/biom13081250 · Cited by 42
Xue, Y., Riva, N., Zhao, L., Shieh, J.-S., Chin, Y., Gatt, A., & Guo, J. J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.031 · Cited by 43
Advances in the study of plant-derived extracellular vesicles in the skeletal muscle system
Mao, X., Li, T., Qi, W., Miao, Z., Zhu, L., Zhang, C., Jin, H., Pan, H., & Wang, D. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107202 · Cited by 42
Hodgson‐Garms, M., Moore, M., Martino, M. M., Kelly, K., & Frith, J. E. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-024-00382-y · Cited by 50
Khan, A. A., Huat, T. J., Mutery, A. A., El-Serafi, A. T., Kacem, H. H., Abdallah, S. H., Reza, M. F., Abdullah, J. M., & Jaafar, H. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00487-z · Cited by 43
Adipose-Derived Stem Cell Conditioned Medium and Wound Healing: A Systematic Review
Zhang, B., Wu, Y., Mori, M., & Yoshimura, K. (2021) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2021.0100 · Cited by 42
“15,19,21 Cell therapies are strictly regulated by each government policy and law to confirm their safety.”
Zagoura, D., Trohatou, O., Makridakis, M., Kollia, A., Kokla, N., Mokou, M., Psaraki, A., Eliopoulos, A. G., Vlahou, A., & Roubelakis, M. G. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.009 · Cited by 39
“More importantly, this cell free therapeutic approach can be manipulated for safety and dosage as a common pharmaceutical agent [44].”
BackgroundSendón-Lago, J., Rio, L. G., Eiró, N., Díaz‐Rodríguez, P., Ávila, L., Gonzalez, L. O., Vizoso, F. J., Pérez-Fernández, R., & Landín, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081127 · Cited by 39
“Therefore, secretome derivatives, such as CM or exosomes, may be preferable to cell administration in terms of manufacturing, storage, and handling [48].”
BackgroundSelf-citationDevelopment of a Lyophilized Off-the-Shelf Mesenchymal Stem Cell-Derived Acellular Therapeutic
Driscoll, J., Yan, I. K., & Patel, T. C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040849 · Cited by 41
“The MSC-secretome has a better safety profile, due to the acellular nature of the material; namely, it is less immunogenic, and has negligible tumorigenic potential [22,23].”
BackgroundDevelopment of MicroRNA-146a-Enriched Stem Cell Secretome for Wound-Healing Applications
Waters, R., Subham, S., Pacelli, S., Modaresi, S., Chakravarti, A. R., & Paul, A. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00639 · Cited by 40
Mesenchymal stromal cell secretome as a therapeutic strategy for traumatic brain injury
Muhammad, S. A. (2019) · BioFactors · doi:10.1002/biof.1563 · Cited by 39
Taei, A. A., Dargahi, L., Khodabakhsh, P., Kadivar, M., & Farahmandfar, M. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13886 · Cited by 44
Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis
Liu, P., Qian, Y., Liu, X., Zhu, X., Zhang, X., Lv, Y., & Xiang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1096402 · Cited by 37
“Frontiers in Immunology 03 IL-6, IL-8, and IL-9) to mediate their immunomodulatory effects (54).”
BackgroundZou, X., Zou, D., Li, L., Yu, R., Li, X., Du, X.-Y., Guo, J., Wang, K., & Liu, W. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03137-y · Cited by 42
“However, the use of stem cells has certain limitations, including maintaining biological activity, quantification of biologically active substances, and logistics and distribution [23].”
BackgroundHuňáková, K., Hluchý, M., Špaková, T., Matejová, J., Mudroňová, D., Kuricová, M., Rosocha, J., & Ledecký, V. (2020) · Research in Veterinary Science · doi:10.1016/j.rvsc.2020.08.004 · Cited by 37
Current advances of stem cell-based therapy for kidney diseases
Wong, C. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i7.914 · Cited by 39
Extracellular vesicles and their role in peripheral nerve regeneration
Hercher, D., Nguyen, M. Q., & Dworak, H. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113968 · Cited by 39
Shah, S., Esdaille, C. J., Bhattacharjee, M., Kan, H.-M., & Laurencin, C. T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116865118 · Cited by 38
Unraveling the therapeutic effects of mesenchymal stem cells in asthma
Mirershadi, F., Ahmadi, M., Rezabakhsh, A., Rajabi, H., Rahbarghazi, R., & Keyhanmanesh, . (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01921-2 · Cited by 38
de Miguel–Gómez, L., Romeu, M., Pellicer, A., & Cervelló, I. (2021) · Molecular Reproduction and Development · doi:10.1002/mrd.23523 · Cited by 38
“and angiogenic properties and promotes wound healing and tissue repair (Vizoso et al., 2017).”
BackgroundAliakbari, F., Marzookian, K., Parsafar, S., Hourfar, H., Nayeri, Z., Fattahi, A., Raeiji, M., Boroujeni, N. N., Otzen, D. E., & Morshedi, D. (2024) · Science Advances · doi:10.1126/sciadv.adl3406 · Cited by 47
“MSCs have two distinct therapeutic properties, namely, multipoten-tiality (the ability to differentiate into different types of cells) and the secretion of active compounds, which may be contained in extracellular vehicles such as exosomes (Ex) ( 19 , 20 ).”
BackgroundMesenchymal Stem Cell Engineered Nanovesicles for Accelerated Skin Wound Closure
Han, C., Jeong, D., Kim, B., Jo, W., Kang, H., Cho, S., Kim, K. H., & Park, J. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01646 · Cited by 37
Purity Determines the Effect of Extracellular Vesicles Derived from Mesenchymal Stromal Cells
Forteza‐Genestra, M. A., Antich-Rosselló, M., Calvo, J., Gayà, A., Monjo, M., & Ramis, J. M. (2020) · Cells · doi:10.3390/cells9020422 · Cited by 41
“Mesenchymal Stromal Cells (MSCs) play an important role in cell therapy and in regenerative medicine due to their capability to differentiate in different cell types depending on the experimental or physiological conditions [1].”
BackgroundMesenchymal Stromal Cells as Potential Antimicrobial for Veterinary Use—A Comprehensive Review
Russell, K. A., Garbin, L. C., Wong, J. M., & Koch, T. G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.606404 · Cited by 37
“It removes some safety risks associated with live cell transplantations including immune compatibility and tumorigenicity (Vizoso et al., 2017).”
BackgroundThe secretome of endothelial progenitor cells: a potential therapeutic strategy for ischemic stroke
Bayraktutan, U., Alwjwaj, M., & Kadir, R. R. A. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303012 · Cited by 37
“EPC secretome-mediated suppression of inflammation alongside the regulation of angiogenesis, functional recovery and axonal regeneration has also been implicated in neuroprotection in a rat model of spinal cord injury (Wang et al., 2018).”
BackgroundHolkar, K., Kale, V. P., & Ingavle, G. C. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00386 · Cited by 36
Zhu, Q., Tang, S., Zhu, Y., Chen, D., Huang, J., & Lin, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.868734 · Cited by 37
“Despite the promise of stem cell-based therapy, these strategies are limited by the potential for tumorigenicity, emboli formation, immunogenicity, and infectious disease transmission associated with such treatments (Vizoso et al., 2017).”
Background
Metadata
- Authors
- Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R.
- Affiliations
- Fundación Hospital de Jove (ES)
- Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33290 Gijón, Spain
- Department of Obstetrics & Gynecology, C/Ramon y Cajal 7, University of Valladolid, 47005 Valladolid, Spain
- Department of Physiology-Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Santiago de Compostela, Spain
- Corresponding author
- Vizoso, Francisco
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-25
- Volume
- 18
- Issue
- 9
- Pages
- 1852
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5618501
- OpenAlex
- W2746710261
- Cited by
- 1,363
- References
- 235
- Citations by year
- 2026: 142 · 2025: 165 · 2024: 153 · 2023: 182 · 2022: 186 · 2021: 178 · 2020: 158 · 2019: 130 · 2018: 62 · 2017: 6
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Council
- European Regional Development Fund (SAF2015-69221-R)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, cell-free therapy, conditioned medium, exosomes, regenerative medicine, stem cell therapy, quality control, regulatory requirements
- MeSH terms
- Clinical Studies as Topic, Animals, Humans, Stem Cells, Culture Media, Conditioned, Regenerative Medicine, Mesenchymal Stem Cell Transplantation, Cell-Derived Microparticles, Exosomes, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.